Company: CGCT
Filing Date: 2025-01-29
Form Type: S-1
Source: 0001104659-25-006780
Chunk: 242

Company: Cartesian Growth Corp III
Filing Date: 2025-01-29
Form: S-1
Chunk 242
---
 to our board of directors with respect to the compensation, and any       
 incentive compensation and equity based plans that are subject to board approval of all of our other officers; |

| · | reviewing our executive compensation policies and plans; |

| · | implementing and administering our incentive compensation equity-based remuneration plans; |

| · | assisting management in complying with our proxy statement and annual report disclosure requirements; |

| · | approving all special perquisites, special cash payments and other special compensation and benefit arrangements 
 for our executive officers and employees;                                                                        |

| · | producing a report on executive compensation to be included in our annual proxy statement; and |

| · | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |

The charter will also provide that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will
be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving
advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence
of each such adviser, including the factors required by Nasdaq and the SEC.

Director Nominations

We do not have a standing nominating committee
though we intend to form a corporate governance and nominating committee as and when required to do so by law or Nasdaq rules. In accordance
with Rule 5605(e)of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by our
board of directors. Our board of directors believes that the independent directors can satisfactorily carry out the responsibility of
properly selecting or approving director nominees without the formation of a standing nominating committee. The directors who will participate
in the consideration and recommendation of director nominees are Ali Bouzarif, Kevin Gold and Sanford Litvack. In accordance with Rule 5605(e)(1)(A) of
the Nasdaq rules, all such directors are independent. As there is no standing nominating committee, we do not have a nominating committee
charter in place.

<div align='center'>127</div>

The board of directors will also consider director
candidates recommended for nomination by our shareholders during such times as they are seeking proposed nominees to stand for appointment
at the next annual general meeting (or, if applicable, an extraordinary general meeting). Our shareholders that wish to nominate a director
for appointment to our board of